What this means
This trial is still recruiting people, and no results have been posted yet. It will check whether the gel seems safe and helpful, and it does not show it works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–70
- Where
- 1 site
The science
- Registered title
- Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
- Trial ID
- NCT06962345 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause, Quality of Life, Menopause Related Conditions, Dyspareunia, Urinary Incontinence, Urgency-frequency, Sexual Function, Women´s Health, Vaginal Dryness
- What is tested
- Hormone-free vulvovaginal gel with the tested composition XCMIM20m
- Sponsor
- Mucosa Innovations, S.L.
- Ages
- 40 Years to 70 Years
- Dates
- First posted May 8, 2025 · updated Mar 30, 2026
Registry summary
The goal of this clinical trial is to improve the management of Genitourinary syndrome of menopause (GSM) to preliminary assess safety and effectivity of a novel hormone-free mucosa composition (XCMIM20m) applied topically to the vulvovaginal area. Symptoms of vaginal atrophy will be compared before and after 8 weeks of use of the tested gel with the Day-to-Day Impact of Vaginal Aging (DIVA) PROMs questionnaire to assess changes impact of GSM symptoms.
Sites (1)
- Mucosa Innovations S.L., Madrid, Madrid, Spain